Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - oseltamivirum - capsule - oseltamivirum 75 mg ut oseltamiviri phosphas, amylum pregelificatum, povidonum k 30, carmellosum natricum conexum, talcum, natrii stearylis fumaras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: lacca, alcohol butylicus, e 171, e 132, ethanolum anhydricum, methanolum, pro capsula corresp. natrium 409.7 µg. - influenza a e b - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - oseltamivirum - capsule - oseltamivirum 30 mg ut oseltamiviri phosphas, amylum pregelificatum, povidonum k 30, carmellosum natricum conexum, talcum, natrii stearylis fumaras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, alcohol butylicus, e 171, e 132, ethanolum anhydricum, methanolum, pro capsula corresp. natrium 163.8 µg. - influenza a e b - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - oseltamivirum - capsule - oseltamivirum 45 mg ut oseltamiviri phosphas, amylum pregelificatum, povidonum k 30, carmellosum natricum conexum, talcum, natrii stearylis fumaras, kapselhülle: gelatina, e 171, e 172 (nigrum), drucktinte: lacca, alcohol butylicus, e 171, e 132, ethanolum anhydricum, methanolum, pro capsula corresp. natrium 245.8 µg. - influenza a e b - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - oseltamivirum - polvere per sospensione orale - oseltamivirum 6 mg ut oseltamiviri phosphas 7.88 mg, sorbitolum 171.42 mg, xanthani gummi, natrii dihydrogenocitras anhydricus, saccharinum natricum, e 171, e 211 0.5 mg, aromatica, ad pulverem corresp., suspensio reconstituta 1 ml corresp. natrium 1.28 mg. - terapia e profilassi dell'influenza - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - mofetili mycophenolas - capsule - mofetili mycophenolas 250 mg, carmellosum natricum solo unita, colore.: e 132, excipiens pro capsula. - immunsuppressivum - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - mofetili mycophenolas - compresse rivestite con film - mofetili mycophenolas 500 mg, carmellosum natricum solo unita, colore.: e 132, excipiens pro compresso haze. - immunsuppressivum - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - mofetili mycophenolas - polvere per sospensione orale - mofetili mycophenolas 200 mg, lecithinum ex soja, arom.: vanillinum et alia, aspartamum, sorbitolum, conserv.: e 218, excipiens ad pulverem corresp. suspensio reconstituta 1 ml. - immunsuppressivum - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - ribavirinum - compresse rivestite con film - ribavirinum 200 mg, excipiens pro compresso obducto. - l'epatite c cronica, terapia di associazione con interferone - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - ribavirinum - compresse rivestite con film - ribavirinum 400 mg, excipiens pro compresso obducto. - l'epatite c cronica, terapia di associazione con interferone - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - enfuvirtidum - soluzione iniettabile - praeparatio cryodesiccata: enfuvirtidum 90 mg, natrii carbonas, mannitolum, natrii hydroxidum aut acidum hydrochloridum, pro vitro corresp. natrium 1.037 mg. solvens: aqua ad iniectabile pro vitro. - le infezioni da hiv - synthetika